共 50 条
- [44] ACTIVITY OF PHASE-I DRUGS HOMOHARRINGTONINE (HHT) AND TRICYCLIC NUCLEOTIDE (TCN) AGAINST SURGICAL EXPLANTS OF HUMAN-TUMORS IN THE 6-DAY SUBRENAL CAPSULE (SRC) ASSAY [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1982, 23 (MAR): : 222 - 222
- [47] SCC-antigen, a tumor marker with poor reliability for ENT, head and neck carcinomas. The role of the squamous cell carcinoma-antigen (SCC-A) in diagnosis and follow-up of patients with squamous cell carcinoma (SCC) of the head and neck. Results of a six years retrospective study. [J]. LARYNGO-RHINO-OTOLOGIE, 1998, 77 (03) : 165 - 167
- [48] Clinical Performance of the APTIMA HPV Assay for the Detection of High-Risk HPV in Head and Neck Squamous Cell Carcinomas [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2016, 18 (06): : 1013 - 1013
- [49] COMPARATIVE TRIAL OF CIS-PLATINUM (C) ONCOVIN (O) AND BLEOMYCIN (B) VS METHOTREXATE (M) IN PATIENTS WITH ADVANCED EPIDERMOID CARCINOMAS OF THE HEAD AND NECK [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 202 - 202